Pharmaceutical followers

Peter Arcidiacono, Paul B. Ellickson, Peter Landry and David Ridley

International Journal of Industrial Organization, 2013, vol. 31, issue 5, 538-553

Abstract: We estimate a model of drug demand and supply that incorporates insurance, advertising, and competition between branded and generic drugs within and across therapeutic classes. We use data on antiulcer drugs from 1991 to 2010. Our simulations show that generics and “me-too” drugs each increased consumer welfare more than $100million in 2010, holding insurance premiums constant. However, insurance payments in 2010 fell by nearly $1billion due to generics and rose by over $7billion due to me-too antiulcer drugs.

Keywords: Pharmaceuticals; Me-too drugs; Generics; Pricing (search for similar items in EconPapers)
JEL-codes: I11 L13 L65 (search for similar items in EconPapers)
Date: 2013
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (16)

Downloads: (external link)
http://www.sciencedirect.com/science/article/pii/S0167718713000957
Full text for ScienceDirect subscribers only

Related works:
Working Paper: Pharmaceutical Followers (2013)
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eee:indorg:v:31:y:2013:i:5:p:538-553

DOI: 10.1016/j.ijindorg.2013.10.005

Access Statistics for this article

International Journal of Industrial Organization is currently edited by P. Bajari, B. Caillaud and N. Gandal

More articles in International Journal of Industrial Organization from Elsevier
Bibliographic data for series maintained by Catherine Liu ().